share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Bhatt Deepak

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施贵宝 | 4：持股变动声明
SEC announcement ·  04/02 18:41
Moomoo AI 已提取核心信息
In a recent transaction, Bhatt Deepak, associated with Bristol-Myers Squibb (BMY), was reported to have engaged in a market action on March 31, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting ownership stake, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
In a recent transaction, Bhatt Deepak, associated with Bristol-Myers Squibb (BMY), was reported to have engaged in a market action on March 31, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting ownership stake, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
据报道，在最近的一笔交易中，与百时美施贵宝（BMY）有联系的巴特·迪帕克于2024年3月31日参与了市场活动。该交易的具体细节，包括所涉及的股票数量、股票的性质、交易价格以及由此产生的所有权，均未在公告中披露。这些信息对于投资者了解交易对其投资决策的影响至关重要。
据报道，在最近的一笔交易中，与百时美施贵宝（BMY）有联系的巴特·迪帕克于2024年3月31日参与了市场活动。该交易的具体细节，包括所涉及的股票数量、股票的性质、交易价格以及由此产生的所有权，均未在公告中披露。这些信息对于投资者了解交易对其投资决策的影响至关重要。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息